Ergoteles LLC Repligen Corp Transaction History

Ergoteles LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $36,681 - $47,782	265 Added 9.88%	2,947 $416,000
Q1 2023 May 10, 2023	BUY	$154.26 - $198.1 $413,725 - $531,304	2,682 New	2,682 $451,000
Q1 2022 May 13, 2022	SELL	$161.19 - $257.96 $894,443 - $1.43 Million	-5,549 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $12.8 Million - $15.7 Million	-51,503 Reduced 90.27%	5,549 $1.47 Million
Q3 2021 Nov 15, 2021	BUY	$194.77 - $324.21 $10.8 Million - $18 Million	55,495 Added 3564.23%	57,052 $16.5 Million
Q2 2021 Aug 12, 2021	BUY	$165.87 - $220.95 $258,259 - $344,019	1,557 New	1,557 $311,000
Q1 2021 May 12, 2021	SELL	$180.37 - $226.26 $2.37 Million - $2.97 Million	-13,134 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$148.08 - $206.57 $1.94 Million - $2.71 Million	13,134 New	13,134 $2.52 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.